Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.45 CHF | +0.84% | -.--% | -.--% |
31/05 | Qiagen, Myriad Genetics Team Up to Develop Homologous Recombination Deficiency Test | MT |
31/05 | Qiagen, Myriad Genetics Partner to Create Easily Distributable Cancer Tumor Test | MT |
- Stock Market
- Equities
- QGEN Stock
- QGEN Stock
- News Qiagen N.V.